褪黑激素市場按來源、類型、最終用戶和地區分類（2026 年至 2032 年）

褪黑激素市場評估（2026-2032）

隨著人們對睡眠障礙的認知不斷提高以及褪黑素補充劑的益處日益凸顯，褪黑素產業正在迅速擴張。壓力水平的上升、老年人口的成長以及人們對自然療法的追求，都推動了市場的成長。北美市場佔有率。因此，預計2024年市場規模將超過18.6億美元，到2032年將達到約49.3億美元。

褪黑素配方技術的進步和線上零售業的蓬勃發展正在推動市場擴張。對客製化健康和保健解決方案的需求也推動了市場需求的成長。 Natrol、Life Extension 和 Swanson Health Products 是主要的市場參與企業，它們正在透過產品創新和策略聯盟鞏固其市場地位。褪黑素需求的不斷成長，使得市場在 2026 年至 2032 年期間的複合年成長率達到 14.30%。

褪黑激素市場定義/概述

褪黑激素是一種由大腦松果體分泌的天然激素，能夠調節睡眠-覺醒週期。它通常被用作膳食補充劑，透過促進放鬆和改善睡眠品質來幫助治療與睡眠障礙、時差反應和輪班工作相關的問題。

褪黑激素常用於調節睡眠-覺醒週期、治療失眠和預防時差反應。它也用於治療兒童睡眠障礙、術前焦慮以及輪班工人的睡眠鞏固。褪黑激素還具有抗氧化特性，可能有助於改善眼睛健康和季節性情感障礙 (SAD)。

除了調節睡眠，褪黑素的未來用途還可能包括緩解情緒障礙、時差反應和增強免疫力。隨著對其抗氧化和抗發炎特性的研究不斷深入，褪黑素或將擁有更廣泛的藥用價值，並在整體健康和保健策略中發揮更重要的作用。

人們對睡眠障礙的認知不斷提高會推動褪黑激素市場的成長嗎？

鑑於睡眠障礙在美國的盛行率很高，人們對睡眠障礙認知的提高將顯著促進褪黑激素市場的成長。

根據美國疾病管制與預防中心 (CDC) 的數據，約有 7,000 萬美國患有慢性睡眠問題，包括失眠、睡眠呼吸中止症和睡眠不足等多種症狀。美國睡眠美國的數據顯示，美國有 5,000 萬至 7,000 萬成年人患有一種或多種睡眠問題。

這種日益成長的認知導致消費者對褪黑激素補充劑的需求增加，並加深了對褪黑激素在調節睡眠模式和改善整體睡眠品質方面的作用的認知。美國國家衛生統計中心報告稱，2007 年至 2012 年間，美國褪黑激素補充劑的使用量顯著增加，從人口的 0.6% 增加到 1.3%，增加了一倍多。這一發展反映了人們越來越傾向於自然健康療法和量身定做的健康解決方案，褪黑激素補充劑越來越受歡迎，因為它們被認為可有效治療睡眠障礙。隨著人們認知的提高以及褪黑激素產品配方和分銷管道的發展，市場可能會進一步擴大，以滿足不斷成長的客戶需求和偏好。

安全性問題和日益增加的副作用是否會阻礙褪黑激素市場的發展？

褪黑素使用相關的安全隱患和不良反應日益增多，可能會阻礙該行業的發展。雖然褪黑素通常被認為對成人短期使用是安全的，但其長期安全性以及與其他藥物可能產生的相互作用仍存在疑問。雖然觀察到了日間嗜睡、頭痛和頭暈等不良症狀，但並不常見。此外，全球監管環境不同，導致標準和監管也存在差異，可能會損害消費者信心。

透過嚴謹的研究、更完善的標籤以及對醫療保健專業人員的教育來解決這些安全問題，對於避免重大的市場損失至關重要。在人們健康意識日益增強、助眠產品需求日益旺盛的背景下，公開潛在風險和益處的透明度以及合理的行銷策略，對於維護消費者信任並確保褪黑素行業持續擴張至關重要。

目錄

第1章 引言

• 市場定義
• 細分市場
• 分析方法

第2章執行摘要

• 主要發現
• 市場概覽
• 市場亮點

第3章市場概述

• 市場規模和成長潛力
• 市場趨勢
• 市場促進因素
• 市場限制
• 市場機會
• 波特五力分析

第4章 褪黑素市場（依來源）

• 植物
• 動物
• 細菌

第5章 褪黑激素市場（依類型）

• 天然褪黑激素
• 合成褪黑激素

第6章 褪黑素市場（依最終用戶）

• 製藥
• 食品/飲料
• 醫療保健

第7章區域分析

• 北美洲
• 美國
• 加拿大
• 墨西哥
• 歐洲
• 英國
• 德國
• 法國
• 義大利
• 亞太地區
• 中國
• 日本
• 印度
• 澳洲
• 拉丁美洲
• 巴西
• 阿根廷
• 智利
• 中東和非洲
• 南非
• 沙烏地阿拉伯
• 阿拉伯聯合大公國

第8章市場動態

• 市場促進因素
• 市場限制
• 市場機會
• 感染疾病 -19對市場的影響

第9章 競爭態勢

• 主要企業
• 市場佔有率分析

第10章 公司簡介

• Pharmative
• Nature's Bounty
• Jameison
• Rexall Sundown
• GNC
• Xiu Zheng
• Finex OY
• Church & Dwight
• By-Health
• Pfizer
• Solgar
• Biotics Research
• New Food
• Neurim Pharmaceuticals Ltd.
• Pulse Pharmaceuticals Pvt. Ltd.
• Schiff Nutrition International, Inc.
• Fidia Farmaceutici SPA

第11章 市場展望與機會

• 新興技術
• 未來市場趨勢
• 投資機會

第12章 附錄

• 簡稱列表
• 來源和參考文獻

Melatonin Market Valuation - 2026-2032

The melatonin industry is expanding rapidly, driven by increased awareness of sleep disorders and the benefits of melatonin supplementation. Rising stress levels, a growing older population, and a shift toward natural health therapies are all contributing to market growth. North America offers a significant market share. This is likely to enable the market size surpass USD 1.86 Billion valued in 2024 to reach a valuation of around USD 4.93 Billion by 2032.

Technological advances in melatonin product formulations, as well as the growing online retail sector, are driving market expansion. The push toward tailored health and wellness solutions is also driving up demand. Natrol, Life Extension, and Swanson Health Products are key industry participants that rely on product innovation and strategic collaborations to strengthen their market positions. The rising demand for Melatonin is enabling the market grow at a CAGR of 14.30% from 2026 to 2032.

Melatonin Market: Definition/ Overview

Melatonin is a natural hormone produced by the pineal gland in the brain that regulates the sleep-wake cycle. It is commonly used as a dietary supplement to assist treat sleep disorders, jet lag and shift work-related concerns by encouraging relaxation and enhancing sleep quality.

Melatonin is generally used to regulate sleep-wake cycles, treat insomnia, and prevent jet lag. It is also used to treat sleep abnormalities in children, anxiety prior to surgery, and enhancing sleep in shift workers. Melatonin also possesses antioxidant capabilities that may aid eye health and seasonal affective disorder (SAD).

Melatonin's future applications may include mood disorders, jet lag, and immunological support, in addition to sleep regulation. Ongoing research into its antioxidant and anti-inflammatory qualities may lead to larger medicinal applications, bolstering its significance in holistic health and wellness strategies.

Will Increasing Awareness of Sleep Disorders Boost the Melatonin Market Growth?

Increasing awareness of sleep disorders is poised to significantly boost the melatonin market growth due to the substantial prevalence of these conditions among the American population.

According to the Centers for Disease Control and Prevention (CDC), around 70 million Americans suffer from chronic sleep issues, which include a variety of illnesses such as insomnia, sleep apnea and inadequate sleep length. According to the American Sleep Association, 50-70 million adults in the United States suffer from one or more sleep problems.

This increasing awareness is translating into increased consumer demand for melatonin supplements, which is driven by a better knowledge of melatonin's role in regulating sleep patterns and improving overall sleep quality. From 2007 to 2012, the National Center for Health Statistics reported a significant increase in melatonin supplement use in the United States, more than doubling from 0.6% to 1.3% of the population. This development mirrors a broader shift toward natural health therapies and individualized wellness solutions, with melatonin supplements becoming increasingly popular for their perceived effectiveness in treating sleep disturbances. As awareness grows, along with developments in melatonin product formulations and distribution channels, the market is likely to expand further to accommodate expanding customer wants and preferences.

Will Increasing Safety Issues and Adverse Effects Hamper the Melatonin Market?

Increasing safety concerns and undesirable consequences connected with melatonin use have the potential to stifle industry growth. While melatonin is generally deemed safe for short-term usage in adults, there are questions about its long-term safety and potential interactions with other drugs. Adverse symptoms such as daytime drowsiness, headaches and dizziness have been observed, but infrequently. Furthermore, the regulatory landscape differs globally, resulting in different standards and oversight, which can undermine consumer confidence.

Addressing these safety concerns through rigorous research, better labelling and healthcare provider education is critical to avoiding significant market losses. Transparency regarding potential hazards and benefits, together with appropriate marketing techniques, will be vital for maintaining consumer trust and guaranteeing the sustained expansion of the melatonin industry amidst rising health awareness and demand for sleep aids.

Category-Wise Acumens

Will Established Extraction Processes Drive the Plant Segment?

Established extraction technologies for melatonin from plants are expected to fuel expansion in the plant segment of the melatonin market. These techniques have streamlined production, resulting in constant quality and quantity of melatonin supplements. Manufacturers profit from efficient extraction processes that enhance productivity while maintaining melatonin's bioactivity, allowing them to efficiently meet consumer demands.

Furthermore, these proven techniques improve the stability and scalability of plant-derived melatonin products, increasing market competitiveness. Consumer preference for natural sources strengthens this category, as plant-based supplements coincide with expanding trends in holistic health and wellness. The regulatory clarity and safety characteristics associated with plant-derived melatonin further boost market confidence.

As awareness of melatonin's benefits continues to develop, bolstered by known extraction technologies, the plant sector is well-positioned to expand, supplying to increasing consumer interest in natural sleep aids and overall well-being.

Will Increasing Demand for High Purity and Consistency in Dosage Drive the Type Segment?

The growing need for high purity and uniformity in dosage is an important driver for the type segment of the melatonin market, particularly for synthetic melatonin. Consumers and healthcare practitioners alike value products with consistent and accurate dosing to ensure efficacy and safety in treating sleep problems and other health issues. Synthetic melatonin achieves these criteria effectively thanks to controlled manufacturing techniques that ensure purity and consistency across batches.

Furthermore, the pharmaceutical and nutraceutical businesses favor synthetic melatonin because it can meet demanding regulatory and quality control requirements. As the global market for sleep aids and dietary supplements grows, the emphasis on dependable product performance and consumer trust in dose constancy is anticipated to drive the expansion of synthetic melatonin. However, natural resources such as plant-derived melatonin also play a role, particularly among consumers seeking organic or natural options with perceived health benefits.

Country/Region-wise Acumens

Will Increasing Strong Consumer Base Consuming Dietary Supplements Drive the Market in North America?

North America's robust customer base, which values nutritional supplements, is a primary driver of the region's melatonin industry. Melatonin is becoming increasingly popular as a natural sleep aid and overall wellness supplement among North American consumers. Factors such as hurried lifestyles, rising stress levels and the incidence of sleep disorders all contribute to the need for effective remedies such as melatonin.

Furthermore, North America includes a well-developed healthcare infrastructure and regulatory framework that facilitates the distribution and sale of dietary supplements, including melatonin. Consumers in this region value health and wellness, resulting in steady growth in the market for dietary supplements such as melatonin. As a result, manufacturers and suppliers are eager to innovate and broaden their product offers to meet this growing demand, further propelling market expansion in North America.

Will Increasing Awareness of Sleep Disorders Drive the Market in Asia Pacific Region?

Growing awareness of sleep problems is projected to propel the melatonin market in Asia-Pacific (APAC). As people become more aware of the negative impacts of sleep problems like insomnia and sleep apnea, there is a greater need for effective treatments like melatonin supplements. Sleep disorders are on the rise in countries such as China, Japan and India as a result of changing lifestyles, urbanization and higher stress levels.

Furthermore, the trend towards natural health solutions is gaining traction in APAC, which is consistent with the perceived benefits of melatonin as a natural sleep aid. The region's growing middle-class population and rising disposable incomes drive demand for wellness items. As a result, there is great potential for market expansion in APAC, underpinned by higher consumption, awareness, expanding healthcare infrastructure and the introduction of innovative melatonin products tailored to regional preferences and regulatory requirements.

Competitive Landscape

The melatonin market is a dynamic and competitive space, characterized by a diverse range of players vying for market share. These players are on the run for solidifying their presence through the adoption of strategic plans such as collaborations, mergers, acquisitions, and political support. The organizations are focusing on innovating their product line to serve the vast population in diverse regions.

Some of the prominent players operating in the melatonin market include:

• Pharmative
• Nature's Bounty
• Jameison
• Rexall Sundown
• GNC
• Xiu Zheng
• Finex OY
• Church & Dwight
• By-Health
• Pfizer
• Solgar
• Biotics Research
• New Food
• Neurim Pharmaceuticals Ltd.
• Pulse Pharmaceuticals Pvt. Ltd.
• Schiff Nutrition International, Inc.
• Fidia Farmaceutici S.P.A

Latest Developments

• In January 2023, Pfizer, Inc. increased its commitment to the "Agreement for a Healthier World" by offering its entire portfolio of medicines and vaccines on a not-for-profit basis to improve the health of 1.2 billion people in 45 low-income countries.
• In November 2022, Natrol introduced MelatoninMax, a sleep aid in the form of a single gummy containing 10 mg of melatonin, the maximum recommended dosage.

Melatonin Market, By Category

• Source:
• Plants
• Animals
• Bacteria
• Type:
• Natural Melatonin
• Synthetic Melatonin
• End-User:
• Pharmaceuticals
• Food & Beverage
• Medical & Healthcare
• Region:
• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

TABLE OF CONTENTS

1. INTRODUCTION

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Melatonin Market, By Source

• Plants
• Animals
• Bacteria

5. Melatonin Market, By Type

• Natural Melatonin
• Synthetic Melatonin

6. Melatonin Market, By End-User

• Pharmaceuticals
• Food & Beverage
• Medical & Healthcare

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Pharmative
• Nature's Bounty
• Jameison
• Rexall Sundown
• GNC
• Xiu Zheng
• Finex OY
• Church & Dwight
• By-Health
• Pfizer
• Solgar
• Biotics Research
• New Food
• Neurim Pharmaceuticals Ltd.
• Pulse Pharmaceuticals Pvt. Ltd.
• Schiff Nutrition International, Inc.
• Fidia Farmaceutici S.P.A

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References